Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway

Breast Cancer Research

Volumn 13, Issue 1, 2011, Pages

  Ounzain, Samir ^a   Bowen, Samantha ^a   Patel, Chandrakant ^a   Fujita, Rieko ^a   Heads, Richard J ^b   Budhram Mahadeo, Vishwanie S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; NERVE GROWTH FACTOR; TRANSCRIPTION FACTOR POU4F2; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; SIGNAL PEPTIDE;

ARTICLE; AUTOREGULATION; BINDING SITE; BIOINFORMATICS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE ORDER; GENETICS; HOMEOSTASIS; METABOLISM; MOLECULAR CLONING; MUTATION; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CLONING, MOLECULAR; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HOMEOSTASIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NERVE GROWTH FACTOR; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTOR BRN-3B; TRANSCRIPTION INITIATION SITE;

EID: 84860389155     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2809     Document Type: Article

References (29)

1. Budhram-Mahadeo VS, Latchman DS. Targeting Brn-3b in breast cancer therapy. Expert Opin Ther Targets 2006, 10:15-25. 10.1517/14728222.10.1.15, 16441225.
2. Irshad S, Pedley RB, Anderson J, Latchman DS, Budhram-Mahadeo V. The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J Biol Chem 2004, 279:21617-21627. 10.1074/jbc.M312506200, 14970234.
3. Dennis JH, Budhram-Mahadeo V, Latchman DS. The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells. Oncogene 2001, 20:4961-4971. 10.1038/sj.onc.1204491, 11526481.
4. Samady L, Dennis J, Budhram-Mahadeo V, Latchman DS. Activation of CDK4 Gene Expression in Human Breast Cancer Cells by the Brn-3b POU Family Transcription Factor. Cancer Biol Ther 2004, 3:317-323. 10.4161/cbt.3.3.698, 14726699.
5. Budhram-Mahadeo VS, Irshad S, Bowen S, Lee SA, Samady L, Tonini GP, Latchman DS. Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells. Oncogene 2008, 27:145-154. 10.1038/sj.onc.1210621, 17637757.
6. Budhram-Mahadeo V, Ndisang D, Ward T, Weber BL, Latchman DS. The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene 1999, 18:6684-6691. 10.1038/sj.onc.1203072, 10597274.
7. Lee SA, Ndisang D, Patel C, Dennis JH, Faulkes DJ, D'Arrigo C, Samady L, Farooqui-Kabir S, Heads RJ, Latchman DS, Budhram-Mahadeo VS. Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res 2005, 65:3072-3080.
8. Samady L, Faulkes DJ, Budhram-Mahadeo V, Ndisang D, Potter E, Brabant G, Latchman DS. The Brn-3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells. Int J Cancer 2006, 118:869-878. 10.1002/ijc.21435, 16152597.
9. Budhram-Mahadeo V, Parker M, Latchman DS. POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol Cell Biol 1998, 18:1029-1041. 108815, 9448000.
10. Liu YZ, Boxer LM, Latchman DS. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Res 1999, 27:2086-2090. 10.1093/nar/27.10.2086, 148427, 10219080.
11. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res 2004, 32:W273-W279. 10.1093/nar/gkh458, 441596, 15215394.
12. Loots GG. Genomic identification of regulatory elements by evolutionary sequence comparison and functional analysis. Adv Genet 2008, 61:269-293. full_text, 2882178, 18282510.
13. Burley SK, Roeder RG. Biochemistry and structural biology of transcription factor IID (TFIID). Annu Rev Biochem 1996, 65:769-799. 10.1146/annurev.bi.65.070196.004005, 8811195.
14. Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Ando S, Sisci D. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets 2008, 8:597-610. 10.2174/156800908786241104, 18991569.
15. Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 2006, 95:211-218. 10.1007/s10549-005-9011-0, 16261406.
16. Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H. Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 2001, 276:17864-17870. 10.1074/jbc.M010499200, 11359788.
17. Descamps S, Pawlowski V, Revillion F, Hornez L, Hebbar M, Boilly B, Hondermarck H, Peyrat JP. Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res 2001, 61:4337-4340.
18. Buck MB, Knabbe C. TGF-beta signaling in breast cancer. Ann N Y Acad Sci 2006, 1089:119-126. 10.1196/annals.1386.024, 17261761.
19. Tagliabue E, Castiglioni F, Ghirelli C, Modugno M, Asnaghi L, Somenzi G, Melani C, Menard S. Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells. J Biol Chem 2000, 275:5388-5394. 10.1074/jbc.275.8.5388, 10681513.
20. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet 2005, 365:1727-1741. 10.1016/S0140-6736(05)66546-4, 15894099.
21. Cleator S, Ashworth A. Molecular profiling of breast cancer: clinical implications. Br J Cancer 2004, 90:1120-1124. 10.1038/sj.bjc.6601667, 2409657, 15026788.
22. Liu S, Dontu G, Wicha MS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005, 7:86-95. 10.1186/bcr1021, 1143566, 15987436.
23. Descamps S, Lebourhis X, Delehedde M, Boilly B, Hondermarck H. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J Biol Chem 1998, 273:16659-16662. 10.1074/jbc.273.27.16659, 9642218.
24. Melck D, Rueda D, Galve-Roperh I, De PL, Guzman M, Di MV. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett 1999, 463:235-240. 10.1016/S0014-5793(99)01639-7, 10606728.
25. Sommer S, Fuqua SA. Estrogen receptor and breast cancer. Semin Cancer Biol 2001, 11:339-352. 10.1006/scbi.2001.0389, 11562176.
26. Iwase H. Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 2003, 10:89-96. 10.1007/BF02967632, 12736560.
27. Hart LL, Davie JR. The estrogen receptor: more than the average transcription factor. Biochem Cell Biol 2002, 80:335-341. 10.1139/o02-038, 12123286.
28. Kato S. Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 2001, 8:3-9. 10.1007/BF02967472, 11180760.
29. Chiarenza A, Lazarovici P, Lempereur L, Cantarella G, Bianchi A, Bernardini R. Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. Cancer Res 2001, 61:3002-3008.